Urovax

The urological drug Urovax (Uro-Vax, Uro-vaxom) is widely used as a preventive and therapeutic drug for urinary tract infections.

Indications Urovax

Urovax can be used as part of combination therapy and to prevent the development of repeated episodes of chronic infectious diseases of the urinary system - and especially cystitis, regardless of the etiology of the pathogen.

Urovax is combined with antibiotics and antiseptic drugs as a treatment for adult patients and children over 4 years of age.

Release form

Urovax is a dense gelatin capsule with an orange cap and a yellowish body. The capsule contains a powdery substance of a yellowish-brown hue.

The cardboard box contains three blister packs, 10 capsules in each pack.

The main ingredient of Urovax is Escherichia coli microorganisms: each capsule contains 6 mg of bacteria.

Pharmacodynamics

Urovax stimulates the body's immune defense using the following mechanisms:

• T-lymphocyte stimulation;
• induction of endogenous interferon production;
• increased levels of immunoglobulin A (IgA), including in urine.

Escherichia coli is a type of Gram-negative rod-shaped microorganism belonging to facultative anaerobes that are present in the healthy microflora of the human gastrointestinal system.

The Escherichia coli strain is recognized as one of the most effective probiotics, which is capable of inhibiting the development of the inflammatory process and preventing its relapse.

Pharmacokinetics

The kinetic properties of Urovax have not been studied.

Dosing and administration

Urovax should be taken every day, in the morning, on an empty stomach - until the condition is normalized, but not less than ten days.

The maximum duration of therapy with Urovax is 12 weeks.

As a preventative measure, take one capsule of Urovax before breakfast for 12 weeks.

In pediatrics, preliminary opening of the capsule and mixing of the contents with liquids (juice, milk, etc.) is allowed.

The question of the possibility of using a repeated course of Urovax is decided by the doctor, taking into account the individual characteristics of the patient.

[ 1 ]

Use Urovax during pregnancy

There is currently no information on clinical trials of Urovax during pregnancy.

Previously, relevant tests were conducted on experimental animals. During the studies, no negative impact of Urovax on the course of the gestation period or on the development of the fetus was found.

Given the lack of complete reliable information, it is impossible to recommend Urovax for use during pregnancy and lactation. The decision regarding the possibility of using the medication during the listed periods is made by the attending physician.

Contraindications

Urovax is well tolerated by the human body, so it has virtually no contraindications. Relative contraindications include pregnancy and breastfeeding. Absolute contraindications include hypersensitivity of the patient to the components of Urovax.

Side effects Urovax

During the intake of Urovax, side effects are registered in no more than 4% of cases. Among the negative symptoms, the most frequently observed are:

• diarrhea, nausea, discomfort in the abdomen;
• headaches;
• slight increase in temperature;
• allergic rashes.

If any undesirable symptoms associated with taking Urovax occur, you should stop treatment and consult your doctor.

Overdose

There have been no reports of overdose with Urovax.

By its nature, Urovax is considered a non-toxic drug, so negative consequences from its overdose are unlikely.

Interactions with other drugs

No negative interactions of Urovax with other medications have been found.

In order not to affect the quality of therapy, it is not recommended to use Urovax 14 days before and for 14 days after oral administration of live vaccines.

A neutralizing effect of immunosuppressant drugs on the effectiveness of Urovax is allowed.

[ 2 ], [ 3 ]

Storage conditions

Store Urovax within the temperature range of +15 to +25°C, out of reach of children.

[ 4 ]

Shelf life

Urovax can be stored for up to 5 years.